Financials Mesoblast Limited

Equities

Delayed Australian S.E. Other stock markets 02:50:03 17/03/2026 GMT			5-day change	1st Jan Change
2.025 ^AUD	-1.22%		-7.11%	-25.55%

03-12	Mesoblast Limited Appoints Dr. Teresa Montagut As Head Of Clinical Development And Medical Affairs	CI
03-11	Mesoblast Appoints Head of Clinical Development, Medical Affairs	MT

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	10.22	14.84	11.55	8.7	26.36	179.5	330.2	676.6
Change	-	45.22%	-22.16%	-24.67%	202.94%	581.22%	83.92%	104.91%
EBITDA ¹	-115.9	-101.6	-89.11	-89.14	-111	-2.948	106.2	557.4
Change	-	12.32%	12.27%	-0.03%	-24.54%	97.34%	3,702.1%	424.92%
EBIT ¹	-121.9	-107.9	-95.44	-96.02	-120.8	-30.6	93.11	394.4
Change	-	11.42%	11.59%	-0.61%	-25.84%	74.68%	404.32%	323.6%
Interest Paid ¹	-14.66	-25.12	-30.98	-33.9	-35.2	-33.42	-18.06	-12.47
Earnings before Tax (EBT) ¹	-136.5	-133.1	-126.4	-129.9	-156	-74.04	34.59	313
Change	-	2.55%	4.99%	-2.78%	-20.08%	52.55%	146.72%	804.82%
Net income ¹	-135.4	-132.7	-126.1	-129.7	-156.5	-56.87	53.72	287.3
Change	-	2%	4.99%	-2.83%	-20.73%	63.67%	194.46%	434.86%
Announcement Date	30/08/21	30/08/22	30/08/23	28/08/24	28/08/25	-	-	-

¹AUD in Million

Estimates

Fiscal Period: June	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q2	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	2.47	2.734	4.978	3.342	2.806	3.234	2.267	3.173	2.98	3.294	5.219	42.92	46.59	51.68	66.21	69.09	72.2	80.37
Change	-	10.69%	82.07%	-32.87%	-16.04%	15.27%	-29.9%	39.98%	-6.09%	10.52%	58.46%	722.31%	8.57%	10.91%	28.11%	4.35%	4.5%	11.32%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-30.17	-25.5	-26.38	-28.95	-24.32	-24.94	-18.77	-27.32	-21	-26.96	-	-	-4.651	0.5139	14.27	14.89	15.71	17.18
Change	-	15.48%	-3.47%	-9.74%	15.98%	-2.55%	24.76%	-45.55%	23.13%	-28.39%	-	-	-	111.05%	2,677.68%	4.35%	5.5%	9.33%
Charge d'intérêts ¹	-4.213	-2.194	-5.069	-7.544	-5.455	-6.301	-6.783	-9.202	-7.66	-6.855	-	-	-8.054	-3.003	-	-	-	-
Earnings before Tax (EBT) ¹	-34.33	-30.32	-31.45	-36.49	-29.78	-31.25	-25.55	-36.52	-28.66	-33.81	-	-	-4.651	0.5139	14.27	14.89	15.71	17.18
Change	-	11.67%	-3.72%	-16.04%	18.4%	-4.92%	18.23%	-42.93%	21.53%	-17.99%	-	-	-	111.05%	2,677.68%	4.35%	5.5%	9.33%
Net income ¹	-34.2	-30.23	-31.37	-36.38	-29.72	-31.17	-25.47	-36.41	-28.59	-33.75	-	-	-4.651	0.5139	14.27	14.89	15.71	17.18
Change	-	11.6%	-3.75%	-16%	18.32%	-4.88%	18.29%	-42.98%	21.49%	-18.07%	-	-	-	111.05%	2,677.68%	4.35%	5.5%	9.33%
Announcement Date	03/06/21	30/08/21	23/11/21	24/02/22	01/06/22	30/08/22	22/11/22	27/02/23	25/05/23	30/08/23	28/02/24	26/02/26	-	-	-	-	-	-

¹AUD in Million

Estimates

Fiscal Period: June	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1	2024 S2	2025 S1	2025 S2	2026 S1	2026 S2	2027 S1	2027 S2	2028 S1
Net sales ¹	-	6.156	5.407	5.951	5.219	3.706	4.993	21.52	72.32	105.6	110	135.7	136.7
Change	-	-	-12.16%	10.07%	-12.3%	-29%	34.73%	331.01%	236.05%	46.07%	4.16%	23.31%	0.78%
EBITDA	-52.58	-47.1	-42.56	-45.04	-30.62	-59.84	-55.08	-	-37.54	-	-	-	-
Change	-	10.42%	9.64%	-5.82%	32.01%	-95.4%	7.96%	-	-	-	-	-	-
EBIT ¹	-55.66	-50.28	-45.82	-49.36	-34.39	-63.12	-58.37	-64.29	-43.61	-4.827	-11.11	11.3	-
Change	-	9.67%	8.86%	-7.74%	30.34%	-83.54%	7.52%	-10.14%	32.16%	88.93%	-130.2%	201.69%	-
Charge d'intérêts ¹	-12.68	-11.98	-15.89	-14.53	-15.9	-18.69	-17.13	-18.61	-15.9	-15.36	-17.55	-18.25	-
Earnings before Tax (EBT) ¹	-	-62.26	-61.71	-63.9	-50.28	-81.82	-75.5	-82.89	-55.94	-23.75	-35.07	-19.97	-26.9
Change	-	-	0.88%	-3.54%	21.3%	-62.72%	7.73%	-9.8%	32.51%	57.55%	-47.71%	43.06%	-34.72%
Net income ¹	-	-62.12	-61.52	-62.39	-50.13	-81.69	-75.83	-83.07	-56.57	-23.36	-35.07	-19.97	-26.9
Change	-	-	0.96%	-1.41%	19.66%	-62.97%	7.17%	-9.55%	31.91%	58.71%	-50.15%	43.06%	-34.72%
Announcement Date	24/02/22	30/08/22	27/02/23	30/08/23	28/02/24	28/08/24	26/02/25	28/08/25	26/02/26	-	-	-	-

¹AUD in Million

Estimates

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	-43	-	57.7	75.7	-60.8	-23.9	-138	-636
Change	-	-	-	31.2%	-180.32%	60.67%	-477.41%	-360.87%
Announcement Date	30/08/21	30/08/22	30/08/23	28/08/24	28/08/25	-	-	-

¹AUD in Million

Estimates

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	2.254	0.2281	0.4065	0.3995	1.042	1.361	2.678	2.166
Change	-	-89.88%	78.22%	-1.73%	160.86%	30.57%	96.78%	-19.1%
Free Cash Flow (FCF) ¹	-148.3	-95.8	-97.83	-71.83	-77.6	-62.68	95.52	362.9
Change	-	35.39%	-2.12%	26.57%	-8.03%	19.23%	252.41%	279.93%
Announcement Date	30/08/21	30/08/22	30/08/23	28/08/24	28/08/25	-	-	-

¹AUD in Million

Estimates

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-1,133.78%	-684.53%	-771.52%	-1,024.6%	-421.23%	-1.64%	32.16%	82.38%
EBIT Margin (%)	-1,192.54%	-727.41%	-826.28%	-1,103.66%	-458.45%	-17.04%	28.2%	58.29%
EBT Margin (%)	-1,336.24%	-896.67%	-1,094.53%	-1,493.51%	-592%	-41.24%	10.48%	46.26%
Net margin (%)	-1,325.25%	-894.33%	-1,091.71%	-1,490.27%	-593.92%	-31.68%	16.27%	42.47%
FCF margin (%)	-1,450.88%	-645.57%	-846.99%	-825.64%	-294.42%	-34.91%	28.93%	53.63%
FCF / Net Income (%)	109.48%	72.19%	77.58%	55.4%	49.57%	110.2%	177.8%	126.3%
Profitability
ROA	-13.37%	-	-12.3%	-13.14%	-14.05%	-2.2%	10.7%	35.7%
ROE	-17.48%	-	-16.4%	-17.91%	-17.1%	-4.8%	8.4%	30.7%
Financial Health
Leverage (Debt/EBITDA)	-	-	-0.65x	-0.85x	-	-	-	-
Debt / Free cash flow	-	-	-0.59x	-1.05x	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	22.06%	1.54%	3.52%	4.59%	3.95%	0.76%	0.81%	0.32%
CAPEX / EBITDA (%)	-1.95%	-0.22%	-0.46%	-0.45%	-0.94%	-46.16%	2.52%	0.39%
CAPEX / FCF (%)	-1.52%	-0.24%	-0.42%	-0.56%	-1.34%	-2.17%	2.8%	0.6%
Items per share
Cash flow per share ¹	-0.4826	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	1.9	0.6204	0.7581	0.561	0.702	0.842
Change	-	-	-	-67.34%	22.19%	-26%	25.13%	19.94%
EPS ¹	-0.4476	-0.4091	-0.3412	-0.1313	-0.1296	-0.0598	0.0488	0.294
Change	-	8.6%	16.59%	61.51%	1.29%	53.91%	181.66%	502.46%
Nbr of stocks (in thousands)	647,399	649,912	813,662	1,141,241	1,277,239	1,290,770	1,290,770	1,290,770
Announcement Date	30/08/21	30/08/22	30/08/23	28/08/24	28/08/25	-	-	-